Use of Pap tests for cervical cancer screening and factors related with use in Spain;Uso de la citología de cribado de cérvix y factores relacionados con el uso de la prueba en España

Atencion Primaria

Volumn 33, Issue 5, 2004, Pages 229-234

  Luengo Matos, Setefilla ^a   Munoz Van Den Eynde A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Attitudes; Papanicolaou; Screening; Socioeconomic factors; Vaginal cytological examination

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER SCREENING; DEMOGRAPHY; EARLY DIAGNOSIS; FEMALE; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT INFORMATION; POPULATION DENSITY; PUBLIC HEALTH; SOCIAL ASPECT; SOCIOECONOMICS; SPAIN; UTERINE CERVIX CANCER;

EID: 2542490179     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13059170     Document Type: Article

References (16)

1. Noorani HZ, Arratoon C, Hall A. Assessment of techniques for cervical cancer screening. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 1997. COHTA Report 1997:2E.
2. Sánchez-Seco P. Cáncer de cérvix uterino. Semergen 2002;28:145-52.
3. Torrejón R. Factores de riesgo de cáncer uterino. Estrategias de prevención. Salud total de la mujer 2002;4:23-31.
4. Gálvez-Ibáñez M, González-Enríquez J, Lubián-López M. Cribado de cáncer de cérvix. A quién y cuándo. Aten Primaria 1998;21:234-9.
5. Plan Integral de Atención a la Mujer. Madrid: Instituto Nacional de la Salud. Ministerio de Sanidad y Consumo, 1998.
6. Borrás JM, Guillén M, Sánchez V, Juncà S, Vicente R. Educational. level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev 1999;8:427-34.
7. Risendal B, DeZapien J, Fowler B, Papenfuss M, Giuliano A. Pap smear screening among urban south-western American Indian women. Preventive Medicine 1999;29:510-8.
8. Mandelblat JS, Gold K, O'Malley AS, Taylor K, Cagney K, Hopkins J, et al. Breast and cervix cancer screening among multiethnic women: role of age, health and source of care. Preventive Medicine 1999;28:418-25.
9. Segura-Benedicto A, Spagnolo-de-la Torre E, Sanz-Menéndez S, Andrés-Martínez J. El caso del cáncer de cuello uterino y la frivolización de la prevención masiva. Aten Primaria 1994;13: 516-9.
10. Cerdá Mota T, Fernández Pampillón ME, Puime Montero P, Lorenzo Garcia V. Enquisa de saúde sanitaria y social as mulleres. Galicia 2000. Santiago de Compostela: Xunta de Galicia. Conselleria de Sanidad e Servicios Sociais. Dirección Saúde Pública, 2000.
11. Olazábal-Ulacia JC, Montero-Luengo J, Pastor-Mateos F, Alario-García MJ, García-Paniagua R, Garcìa-Gutié rrez JF. Diez años de citologias de cérvix uterino en un centro de salud. Aten Primaria 1997;20:293-8.
12. Snider JA, Beauvais JE. Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status. Chronic Dis Can 1998;19:19-24.
13. Larsem LPS, Olesen F. Characteristics of subgroups of attenders and non-attenders in an organised screening programme for cervical cancer. J Med Screening 1996;3:133-9.
14. Luengo S, Muñoz A. El uso de la mamografia y de la citología de Papanicolaou para la detección precoz de cáncer de mama y de cérvix en España. N.° 34. Madrid: Agencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud Carlos III, 2003.
15. Scott-Conner C, Christie DW, McGehee R, Anglin BL, Heatherington R. Breast and cervical carcinoma screening services: physicians' perceptions of need. J MSMA 1996;809-15.
16. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 1995;85:840-2.